Cargando…
A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome
BACKGROUND: Autism spectrum disorder (ASD) is now understood to have multiple genetic risk genes and one example is SHANK3. SHANK3 deletions and mutations disrupt synaptic function and result in Phelan-McDermid syndrome (PMS), which causes a monogenic form of ASD with a frequency of at least 0.5% of...
Autores principales: | Kolevzon, Alexander, Bush, Lauren, Wang, A Ting, Halpern, Danielle, Frank, Yitzchak, Grodberg, David, Rapaport, Robert, Tavassoli, Teresa, Chaplin, William, Soorya, Latha, Buxbaum, Joseph D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326443/ https://www.ncbi.nlm.nih.gov/pubmed/25685306 http://dx.doi.org/10.1186/2040-2392-5-54 |
Ejemplares similares
-
Erratum: A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome
por: Kolevzon, Alexander, et al.
Publicado: (2015) -
Neural selectivity for communicative auditory signals in Phelan-McDermid syndrome
por: Wang, A. Ting, et al.
Publicado: (2016) -
Erratum to: Neural selectivity for communicative auditory signals in Phelan-McDermid syndrome
por: Wang, A. Ting, et al.
Publicado: (2016) -
Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome
por: Kolevzon, A., et al.
Publicado: (2022) -
Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring
por: Kolevzon, Alexander, et al.
Publicado: (2014)